Polish startup Evidose raises $500k from Inovo VC and 500 Emerging Europe
Polish wellness tech startup Evidose has raised a $500,000 round from Inovo VC and 500 Emerging Europe to help validate effectiveness of dietary supplements. Evidose is now conducting pilots in Poland and aims for a launch on the European markets early next year. The company told AIN.Capital the news.
- Founded in 2023 by Anna Litwińska and Kacper Zambrzycki, Evidose is at the forefront of innovation in the wellness industry. The company is developing a unique platform that allows manufacturers of dietary supplements and other wellness products to scientifically validate the true effects of their products on consumer well-being.
- Evidose handles every aspect of the testing process. This includes designing the studies, recruiting participants, supervising tests, and analyzing results. Furthermore, Evidose provides and integrates with wearables like Apple Watch, Fitbit, Whoop, and Oura Ring and also uses blood test outcomes and home cognitive tests to gather objective data.
“Our decision to invest in Evidose stems from our confidence in the team’s capability to innovate a distinctive product. The combination of Anna and Kacper’s skills, coupled with their in-depth market insight, positions Evidose to potentially transform the use of supplements and wellness products by both consumers and manufacturers,”Tomasz Swieboda, Managing Partner at Inovo VC, comments.
- Inovo VC is one of the oldest and largest VC funds in Poland with three funds under management. The fund’s main focus is on CEE early-stage startups in industries like healthcare (7 portfolio companies) and AI/ML/developer tools (8 portfolio companies).
Earlier, AIN.Capital talked with Krzysztof Przybylak, a HealthTech investor at Inovo.vc, about the fund’s activities and results. You can read the full interview here:
- 500 Emerging Europe is a venture capital firm focused on helping European startups to scale globally. It is part of 500 Global which has over $1.8 billion in assets under management.
The funds will aid Evidose with the further development of its platform, including automation and expanding its offering to include functional foods, cosmetics, and wellness devices and apps. The company also plans to launch in the UK, Germany, France, and Benelux countries early next year.